48,851
edits
Line 13: | Line 13: | ||
*[[Langerhans cell histiocytosis]]. | *[[Langerhans cell histiocytosis]]. | ||
*Hypereosinophilic syndrome (HES).<ref>{{Cite journal | last1 = Podjasek | first1 = JC. | last2 = Butterfield | first2 = JH. | title = Mortality in hypereosinophilic syndrome: 19 years of experience at Mayo Clinic with a review of the literature. | journal = Leuk Res | volume = 37 | issue = 4 | pages = 392-5 | month = Apr | year = 2013 | doi = 10.1016/j.leukres.2012.12.016 | PMID = 23332454 }}</ref> | *Hypereosinophilic syndrome (HES).<ref>{{Cite journal | last1 = Podjasek | first1 = JC. | last2 = Butterfield | first2 = JH. | title = Mortality in hypereosinophilic syndrome: 19 years of experience at Mayo Clinic with a review of the literature. | journal = Leuk Res | volume = 37 | issue = 4 | pages = 392-5 | month = Apr | year = 2013 | doi = 10.1016/j.leukres.2012.12.016 | PMID = 23332454 }}</ref> | ||
*[[Eosinophilic fasciitis]]. | |||
====Neoplastic related==== | ====Neoplastic related==== |
edits